EDGAR Filing Documents for 0001171843-15-003461

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001171843-15-003461

Filing Date

2015-06-16

Accepted

2015-06-16 17:10:37

Documents

Period of Report

2015-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	f20f_061615.htm	20-F	2861570
2	EXHIBIT 12.1	exh_121.htm	EX-12.1	16864
3	EXHIBIT 12.2	exh_122.htm	EX-12.2	16918
4	EXHIBIT 13.1	exh_131.htm	EX-13.1	5542
5	EXHIBIT 13.2	exh_132.htm	EX-13.2	5697
6		kpmg.jpg	GRAPHIC	3351
7		kpmgsign.jpg	GRAPHIC	2620
8		graph.jpg	GRAPHIC	58686
	Complete submission text file	0001171843-15-003461.txt		2997022

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)